RecruitingNot ApplicableNCT06340620
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Randomized Trial of Endoscopic Ultrasound Examination Using EndoSound Vision System vs. Standard Echoendoscope
Sponsor
Orlando Health, Inc.
Enrollment
140 participants
Start Date
Mar 25, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria2
- Age ≥ 18 years
- Any patient undergoing EUS examination for evaluation of the pancreas, bile duct, mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus, stomach, duodenum or colon.
Exclusion Criteria3
- Age \< 18 years.
- Unable to obtain consent for the procedure from either the patient or LAR.
- Intrauterine pregnancy.
Interventions
DEVICEEndoscopic ultrasound examination
Endoscopic ultrasound examination will be performed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06340620
Related Trials
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT056635158 locations
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT0624477126 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location